Michael Heltzen bought $6,405 of EXOZ
Chief Executive Officer at EXOZYMES INC.. 855 shares at an average of $7.49, traded Aug 25, 2026, filed Sep 2, 2026.
Score components
- +25RoleCEO
- 0Trade size$6k at market
- +3Relative to holdingsHoldings up 6%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-041290, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | POpen-market purchase Common Stock | +4 | $7.58 | $30 | 14,708 | 42 d ago |
| Aug 26, 2026 | POpen-market purchase Common Stock | +251 | $7.35 | $1,845 | 14,704 | 42 d ago |
| Aug 26, 2026 | POpen-market purchase Common Stock | +250 | $7.60 | $1,900 | 14,453 | 42 d ago |
| Aug 25, 2026 | POpen-market purchase Common Stock | +250 | $7.52 | $1,880 | 14,203 | 42 d ago |
| Aug 25, 2026 | POpen-market purchase Common Stock | +100 | $7.50 | $750 | 13,953 | 42 d ago |
| Aug 19, 2026 | AGrant or award Common Stock | +8,841 | $6.40 | $57k | 13,853 | 42 d ago |
Related signals
Other insiders at EXOZYMES INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | EXOZsell EXOZYMES INC. | Tyler Paz Korman Chief Scientific Officer | $15k 1,500 shares | -0% | |
| 36Weak | EXOZbuy EXOZYMES INC. | Michael Heltzen Chief Executive Officer | $11k 1,040 shares | +11% | |
| 40Moderate | EXOZbuy EXOZYMES INC. | Michael Heltzen Chief Executive Officer | $20k 1,888 shares | +95% | |
| 33Weak | EXOZbuy EXOZYMES INC. | Michael Heltzen Chief Executive Officer | $22k 1,984 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.